Stock Market Today, Feb. 24: Broad Rally Lifts Markets As Investors Look Ahead to Nvidia Earnings Tomorrow and Trump's State of the Union

MrDecoder · 2026-02-25T12:38:35+00:00

The stock market rebounded, with the S&P 500, Nasdaq, and Dow all rising after recent declines driven by AI concerns. Key movers included Iovance Biotherapeutics and AMD. Investors are focused on asset-heavy stocks amid ongoing market rotations and upcoming earnings reports.

MrDecoder

2026-02-25 12:38:35

Abstract generation in progress

The S&P 500 (^GSPC +0.77%) rose 0.78% to 6,891.04, the Nasdaq Composite (^IXIC +1.04%) gained 1.04% to 22,863.68, and the Dow Jones Industrial Average (^DJI +0.76%) added 0.76% to 49,174.49 as AI jitters eased.

Market movers

Biotech player Iovance Biotherapeutics jumped 32% on positive sarcoma trial data, while Advanced Micro Devices climbed on reports of a new AI chip deal with Meta Platforms. In staples, **J.M. Smucker **outperformed after a Bank of America upgrade, while General Mills lagged after a downgrade.

What this means for investors

After the market sold off stocks yesterday, thanks to a viral post on AI’s “doomsday potential” and the potential implications of the Supreme Court’s tariff ruling, stocks rebounded broadly today. In less than two months this year, the market has swung from “software stocks might be dying” to “AI stocks spending heavily on capex need to show an ROI in 2026,” creating interesting market rotations.

One such rotation is the ongoing “HALO” trade, where investors buy stocks with “heavy assets, low obsolescence,” which should be less susceptible to AI disruption. Mentioned earlier, J.M. Smucker is a perfect example of this HALO trade. Home to tangible operations that AI can’t immediately overtake, SJM stock has already risen 12% in 2026.

Looking ahead, President Trump’s SOTU speech is tonight, and Nvidia will report earnings tomorrow after market close. The Motley Fool’s Adria Cimino notes that prediction markets see a 95% chance for the company to beat earnings, but the market’s reaction to the data will be another thing.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.